ISS/SIC
Journal (WJS)
Congress
Create Account
Login
International Society of Surgery (ISS)
Société Internationale de Chirurgie (SIC)
Integrated Societies: IATSIC | IASMEN | BSI | ISDS
INCIDENCE AND TYPES OF COMPLICATIONS IN CANCER PATIENTS WITH TOTALLY IMPLANTABLE VENOUS CATHETERS
afgm2011@gmail.com
 
Back
Slot ID
PW03-16
Abstract Title
INCIDENCE AND TYPES OF COMPLICATIONS IN CANCER PATIENTS WITH TOTALLY IMPLANTABLE VENOUS CATHETERS
Author Details
No. of Authors
10
Including the presenting author
Author 1
Mónic Bejarano Castro monica.bejarano@fvl.org.co Fundación Valle del Lili Cali Colombia
Author 2
Mateo Betancourt Cajiao mateo.betancourt@correounivalle.edu.co Fundación Valle del Lili Cali Colombia
Author 3
Diana Montilla García diana.montilla.ga@fvl.org.co Fundación Valle del Lili Cali Colombia
Author 4
Helber Fabian Pérez helber.perez.im@fvl.org.co Fundación Valle del Lili Cali Colombia
Author 5
Laura Ordoñez Arenas laura.ordonez.ar@fvl.org.co Fundación Valle del Lili Cali Colombia
Author 6
Stephania Pardo Otalvaro stephania.pardo@fvl.org.co Fundación Valle del Lili Cali Colombia
Author 7
María Juliana Reyes maria.reyes.ca@fvl.org.co Fundación Valle del Lili Cali Colombia
Author 8
Jessica Largo Ocampo jessica.largo.oc@fvl.org.co Fundación Valle del Lili Cali Colombia
Author 9
Andrés Gempeler Rojas andres.gempeler@fvl.org.co Fundación Valle del Lili Cali Colombia
Author 10
Alberto Federico García afgm2011@gmail.com Fundación Valle del Lili Cali Colombia *
Author 11
Author 12
Presenting Author Name
Alberto García Marin
Presenting Author Email
afgm2011@gmail.com
Presenting Author Country
Colombia
Abstract
Abstract type
Oral or Poster
Introduction *
Totally implantable venous catheters (TIVC) are the standard access for chemotherapy in cancer patients. Although generally safe, they are not free of complications, and local incidence remains poorly documented. Our objective was to describe the incidence of complications and associated factors in patients requiring TIVC for chemotherapy.
Material & Method *
We conducted a retrospective incidence cohort with random sampling of all adult cancer patients who underwent TIVC implantation at a high-complexity hospital in Cali between 2017–2022. We calculated cumulative incidence of pneumothorax, hemothorax, hematoma, infection, sepsis, venous thrombosis, and catheter dysfunction, and assessed associated factors with hypothesis testing.
Results *
We included 645 patients, mean age 58 years; 67% female. The most frequent underlying malignancies were breast (27.0%), stomach (11.5%), lung (6.0%), ovary (5.6%), and colon cancer (5.1%). Most catheters were PowerPort (91%), inserted via the subclavian vein (95%), with reservoirs positioned in the chest (99.2%). Overall complication incidence was 7.8%. The most frequent were bacteremia (2.3%) and local infection (1.9%), followed by venous thrombosis, catheter dysfunction, and pneumothorax (<1% each). A total of 101 catheters (15.7%) were removed: 63% after completion of chemotherapy and 29% due to infection. No factors were identified as significantly associated with increased risk of complications.
Conclusion *
The incidence of complications related to TIVC is low. The most common were bacteremia and local infection, the former not associated with catheter insertion. These findings highlight the importance of standardizing surgical technique and maintaining high-quality postoperative device care.
File Upload #1
Only accept images in .jpg or .png format. The image size must not exceed 1 MB.
File Upload #2
Only accept images in .jpg or .png format. The image size must not exceed 1 MB.
Category
Select Main Category
1 General Topics organized by ISS/SIC
Select Sub Category
1.03 General Surgery
Submission Status
Submitted
Word counter
235
Abstract Prizes
Eligible for the BSI Free Paper Prize
No
- Presenting author must register to the congress by 30 November 2025
- Author must submit a full-length manuscript conforming to the format of orignial articles in the World Journal of Surgery WJS by 30 November 2025
Eligible for the Grassi Prize
No
- Author must be age 40 or younger
- One of the authors must be a member of ISDS
- Presenting author must register to the congress by 30 November 2025
- Author must submit a full-length manuscript to the World Journal of Surgery WJS by 30 November 2025
Eligible for the Kitajima Prize
No
- Author must be age 40 or younger
- One of the authors must be a member of ISDS
- Presenting author must register to the congress by 30 November 2025
- Author must submit a full-length manuscript to the World Journal of Surgery WJS by 30 November 2025
Vimeo Link